“Glaucoma and the Pandemic: A Surgery-Led Approach” brings together a global panel of ophthalmic experts to discuss the impact of COVID-19 measures on glaucoma treatment, the challenges of remote IOP monitoring and the use of surgical innovations.
New York, U.S.A., April 8, 2021 – Missed appointments, delayed prescriptions, disease progression, the need for surgical intervention: this is the real-life impact of the COVID-19 pandemic on glaucoma patients, according to a leading, global panel of experts in a recent roundtable meeting with The Ophthalmologist. And while the ramifications, coupled with those resulting from the delayed training of residents and fellows, will be felt beyond the immediate term, glaucoma doctors have found a silver lining during this challenging time. The creative solutions that they quickly implemented to manage their patients, will likely support the sustainable delivery of good glaucoma patient care well into the future.
Aleksandra Jones, Editor of The Ophthalmologist, says, “Having heard many glaucoma specialists worldwide express great concern over their patients’ care throughout the pandemic, with appointments canceled or postponed and elderly patients avoiding routine visits, I invited four leading experts from four different countries to talk about how they are addressing these challenges. This resulted in an incredibly insightful conversation around risk stratification, virtual visits, remote IOP monitoring, and surgical solutions that every glaucoma specialist, fellow, or resident should watch.”
Recorded in March 2021, the roundtable discussion “Glaucoma and the Pandemic: A Surgery-Led Approach” is available to watch here.
The expert panel included:
The roundtable was sponsored by Headline Sponsor, Allergan, and Supporting Sponsor, Nova Eye Medical, and is available to view at no charge.
About The Ophthalmologist
The Ophthalmologist is a leading publication for professionals in all areas of ophthalmic clinical practice. Through its resources – website, newsletters, webinars, social channels, monthly print magazine, and video – The Ophthalmologist gives its vast audience of readers a truly global and multimedia platform from which to learn, communicate, network, and further the field of ophthalmology.
About Texere Publishing
At Texere Publishing, we deliver fearless, compelling, behind the scenes stories that matter in the life sciences and medicine. Our unrivaled access to key opinion leaders, influencers, scientists, and doctors who are making a difference, means that our readers are connected to the pulse of their fields. Founded in 2012, we have expanded our editorial beat to the world with our presence in the U.S., Canada, and the UK. Visionary. Innovative. Fearless. Join us on our journey to cover the stories that matter to you.
Publishers of The Analytical Scientist, The Cannabis Scientist, The Medicine Maker, The Ophthalmologist, The Pathologist and The Translational Scientist.